Skip to main content

Table 1 Clinicopathological characteristics of clinical samples and expression of ATF5 in 140 bladder cancer

From: Activating transcription factor 5 (ATF5) promotes tumorigenic capability and activates the Wnt/b-catenin pathway in bladder cancer

Characteristics No. patients (%)
Age (years)
 ≤ 60 62 (44.3)
 > 60 78 (55.7)
Gender
 Male 106 (75.7)
 Female 34 (24.3)
Grade
 Low grade 103 (73.6)
 High grade 37 (26.4)
Stage
 Ta, T1 110 (78.6)
 T2–T4 30 (21.4)
Tumor size
 ≤ 3 cm 105 (75.0)
 > 3 cm 35 (25.0)
Multiplicity
 1 97 (69.3)
 > 1 43 (30.7)
Expression of ATF5
 High expression 65 (46.4)
 Low expression 75 (53.6)
Recurrence
 Yes 38 (27.1)
 No 102 (72.9)
Progression
 Yes 26 (18.6)
 No 114 (81.4)